Mentions
Extended reach
Total likes
Video views
AI synopsis
The posts show mixed but generally positive perspectives, such as one user sharing that their children haven't gotten colds since using Broncho VaxOm, indicating personal engagement. However, some comments dismiss it as just another immune stimulant with a similar profile, reflecting moderate interest and engagement levels. The overall tone reveals familiarity and mild enthusiasm rather than strong correction or skepticism.
Most posts express positive sentiment, with some sharing personal success stories about Broncho VaxOm and endorsing its use.
Discussion level appears moderate; some users mention specific experiences, but others dismiss it as similar to other immune stimulants.
Posts include personal anecdotes and references to sourcing the product, indicating a reasonable level of individual engagement.
The discussions suggest some influence on personal health choices but lack broader scientific or policy impact at this stage.
@AndreaMHM Consigue Broncho VaxOm pediátrico. Son lisados bacterianos que estimulan las defensas de los bronquios. Yo le di a mis hijos justo entre los 3 y 5 años por bronquitis recurrentes y hasta hoy ni catarro les da. Lo conseguís en Tapachula. Lee https://t.co/mzKDZkgb6q
@natb_00 Sigue siendo como todos los inmunoestimulantes: “papaya” (y de paso bien caros obvio). doi: 10.1016/j.intimp.2017.10.032 https://t.co/G9ZiNHKGJ8
This presentation discusses controlling respiratory tract infections with a focus on viral RTIs in children, their impact, and potential prevention strategies like immunomodulation using products like BronchoVaxom…
Application of a Mechanistic Model to Design RTI Prophylaxis Trials Natacha Go Novadiscovery SA Lyon France. The video discusses modeling approaches for designing respiratory tract infection (RTI) prevention trials…
RT @micheleconunaL: @AndreaMHM Consigue Broncho VaxOm pediátrico. Son lisados bacterianos que estimulan las defensas de los bronquios. Yo l…
@AndreaMHM Consigue Broncho VaxOm pediátrico. Son lisados bacterianos que estimulan las defensas de los bronquios. Yo le di a mis hijos justo entre los 3 y 5 años por bronquitis recurrentes y hasta hoy ni catarro les da. Lo conseguís en Tapachula. Lee https://t.co/mzKDZkgb6q
@natb_00 Sigue siendo como todos los inmunoestimulantes: “papaya” (y de paso bien caros obvio). doi: 10.1016/j.intimp.2017.10.032 https://t.co/G9ZiNHKGJ8
Yin J, Xu B, Zeng X, Shen K. International Immunopharmacology. 2018;54:198-209. doi:10.1016/j.intimp.2017.10.032. Use of Broncho-Vaxom in Private Practice ...
International Immunopharmacology, 81 , 106269. https://doi.org/10.1016/j.intimp.2020.106269 ... https://doi.org/10.1016/j.foodchem.2017.10.032. Wakamatu, T ...
10.1016/j.chest.2017.01.025. CD001831.pub5. [34] Spurling GK, Del Mar CB ... intimp.2017.10.032. wheeze: systematic review and meta‑analysis[J]. [57] ...
... 10.1016/j.intimp.2017.10.032 doi: 10.1186/s12890-023-02665-4. doi: 10.4193/Rhin19.161. doi: 10.1016/j.ijporl.2013.01.009.".
MO
IJ
TS